Vermillion Wealth Management’s Veracyte VCYT Stock Holding History

Vermillion Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$97	–	2427
2026 Q1	$97	Buy	+3	New	+$111	﹤0.01%	1446

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vermillion Wealth Management's VCYT Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 3 shares — an estimated $97 sold.

Vermillion Wealth Management first reported a position in VCYT in Q1 2026 and held it in 1 quarter. The position peaked at $97 in Q1 2026. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Vermillion Wealth Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 3 Veracyte shares in Q2 2026, an estimated $97.
Vermillion Wealth Management first reported a position in Veracyte in Q1 2026 and held it in 1 quarter.
Vermillion Wealth Management's Veracyte position peaked at $97 in Q1 2026.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.